Wet AMD

Biosimilar

Diabetic Eye Awareness

Diabetic Macular Edema

Diabetic Retinopathy

Geographic Atrophy

Imaging

Inherited Retinal Diseases

Europe

Ophthalmology

Retina Technology

Retinal Surgery

Uveitis

News

All News

Blogs

Media

All Videos

Case-Based Roundtable Series

Expert Interviews

Eyeviews

Insights

Medical World News

Podcasts

Rapid Readouts

Viewpoints

Conference

Conference Coverage

Conference Listing

Publications

Modern Retina Digital Edition

Supplements And Featured Publications

Resources

Between the Lines

CME/CE

EYLEA 8mg for nAMD and DME Treatment

Partners

Subscribe

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Modern Retina | Ophthalmology News, Events & Expert Insights

Facebook

LinkedIn

Spotlight

Clinical

1rem

Novel Drug Delivery Methods and Treatment Approaches for Retinal Diseases

Innovations for Sustained Anti-VEGF Delivery in Retinal Diseases 

Judy Kim, MD and Peter Kaiser, MD present a comprehensive discussion on evolving therapeutic strategies for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), addressing barriers like step therapy, discuss the potential use of biosimilars, along with the efficacy and safety of newer therapies such as faricimab and high-dose aflibercept.

Changing Therapeutic Approaches in Neovascular AMD and DME

Promoting Early Detection and Timely Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Longevity in Anti-VEGF Inhibitors Utilized in AMD/DME

Video Series in available therapies and some that are still in development as well as practical considerations in treatment of wet AMD during the post-pandemic era.

Insights Video Series - Treating AMD in 2020